Work

A phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal carcinoma

Year: 2011

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2011.10.002

Authors: Andrea E. Wahner Hendrickson, Ann L. Oberg, Gretchen Glaser, John K. Camoriano, Prema P. Peethambaram, Gerardo Colon-Otero, Charles Erlichman, S. Percy Ivy, Scott H. Kaufmann, Larry M. Karnitz, Paul Haluska

Institutions: Mayo Clinic, Mayo Clinic in Arizona, Mayo Clinic in Florida, National Cancer Institute

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: Therapeutic targeting of HSP90-dependent signaling, G3873038914, G504453343, Early Therapeutics Development with Phase II Emphasis, G599695825, G6433449787, Paul Calabresi Program in Clinical/Translational Research at Mayo Clinic

OpenAlex ID: W1998044332

FWCI: 2.246

Cites: 31

Cited by: 29

Related to: 10